Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience.
Hashmukh JainAkhil KapoorManju SengarRaajit ChananaHari MenonEpari SridharSiddhartha LaskarArchi AgarwalJayant ShastriNehal KhannaVenkatesh RangarajanBhausaheb BagalJayashree ThoratTanuja ShetSumeet GujralPublished in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion (2021)
DA-R-EPOCH regimen is an effective and tolerable regimen in PMBCL patients even with adverse features.